ITRM

Iterum Therapeutics plc

1.26 USD
-0.01 (-0.79%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Iterum Therapeutics plc stock is down -26.74% since 30 days ago. The next earnings date is Mar 14, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 5 February’s closed higher than January. 100% of analysts rate it a buy.

About Iterum Therapeutics plc

Iterum Therapeutics plc is developing sulopenem, a novel anti-infective compound with oral and IV formulations. The company was incorporated in 2015 and is headquartered in Dublin, Ireland.